Chapter 1. SINGLE-CHANNEL DEEP BRAIN STIMULATION DEVICE MARKET – Scope & Methodology
1.1. Market Segmentation
1.2. Assumptions
1.3. Research Methodology
1.4. Primary Sources
1.5. Secondary Sources
Chapter 2. SINGLE-CHANNEL DEEP BRAIN STIMULATION DEVICE MARKET – Executive Summary
2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)
2.2. Key Trends & Insights
2.3. COVID-19 Impact Analysis
2.3.1. Impact during 2023 – 2030
2.3.2. Impact on Supply – Demand
Chapter 3. SINGLE-CHANNEL DEEP BRAIN STIMULATION DEVICE MARKET – Competition Scenario
3.1. Market Share Analysis
3.2. Product Benchmarking
3.3. Competitive Strategy & Development Scenario
3.4. Competitive Pricing Analysis
3.5. Supplier - Distributor Analysis
Chapter 4. SINGLE-CHANNEL DEEP BRAIN STIMULATION DEVICE MARKET - Entry Scenario
4.1. Case Studies – Start-up/Thriving Companies
4.2. Regulatory Scenario - By Region
4.3 Customer Analysis
4.4. Porter's Five Force Model
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Powers of Customers
4.4.3. Threat of New Entrants
4.4.4. Rivalry among Existing Players
4.4.5. Threat of Substitutes
Chapter 5. SINGLE-CHANNEL DEEP BRAIN STIMULATION DEVICE MARKET - Landscape
5.1. Value Chain Analysis – Key Stakeholders Impact Analysis
5.2. Market Drivers
5.3. Market Restraints/Challenges
5.4. Market Opportunities
Chapter 6. SINGLE-CHANNEL DEEP BRAIN STIMULATION DEVICE MARKET – By Application
6.1 Parkinson’s Disease
6.2. Epilepsy
6.3. Essential Tumors
6.4. Obsessive Compulsory Disorder
6.5. Dystonia
6.6. Others
Chapter 7. SINGLE-CHANNEL DEEP BRAIN STIMULATION DEVICE MARKET– By End-Use
7.1. Hospitals & Clinics
7.2. Ambulatory Surgical Centers
7.3. Neurological Clinics
7.4. Academic and Research Institutes
7.5. Others
Chapter 8. SINGLE-CHANNEL DEEP BRAIN STIMULATION DEVICE MARKET – By Region
8.1. North America
8.2. Europe
8.3.The Asia Pacific
8.4.Latin America
8.5. Middle-East and Africa
Chapter 9. SINGLE-CHANNEL DEEP BRAIN STIMULATION DEVICE MARKET – Company Profiles – (Overview, Product Portfolio, Financials, Developments)
9.1. Medtronic plc
9.2. Abbott (St. Jude Medical)
9.3. Boston Scientific Corporation
9.4. Aleva Neurotherapeutics S.A.
9.5. SceneRay Corporation
9.6. NeuroSigma Inc.
9.7. Renishaw PLC
9.8. LivaNova PLC
9.9. Neuropace Inc.
9.10. Beijing PINS Medical
2850
5250
4500
1800
Frequently Asked Questions
Parkinson's disease, essential tremors, dystonia, and obsessive-compulsive disorder are among the neurological conditions that can be treated using a single-channel deep brain stimulation device. It is made up of a tiny electrode that is inserted into the brain and attached to a pulse generator that is inserted into the chest or belly under the skin.
Delivering electrical impulses to particular regions of the brain that regulate movement and other activities is how a single-channel deep brain stimulation device performs. The symptoms of neurological illnesses are lessened and aberrant brain activity is controlled by the electrical impulses.
Improved motor function, fewer tremors, a better quality of life, and a decrease in medication usage are all advantages of utilizing a single-channel deep brain stimulation device. Additionally, it is a minimally invasive surgery that may be done without an overnight stay.
Candidates for a single-channel deep brain stimulation device include frequently those with neurological disorders such as Parkinson's disease, essential tremors, dystonia, or obsessive-compulsive disorder who have not responded well to medication or other therapy.
Utilizing a single-channel deep brain stimulation device has several dangers, such as the potential for infection, hemorrhage, stroke, seizures, and device failure. These dangers are nonetheless minimal, and the procedure's advantages frequently outweigh its drawbacks.